Market Place
Sourcing Support
F-star bags Takeda tie-up in a year with multi-specific antibodies for cancer
06 Jul 2023 //
ENDPTS
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
08 Mar 2023 //
BUSINESSWIRE
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX
07 Mar 2023 //
GLOBENEWSWIRE
F-star`s sale to Chinese buyer cleared by CFIUS following months of holdup
07 Mar 2023 //
ENDPTS
F-star Therapeutics Stock Jumps on Extension to Invox Pharma Merger Deadline
01 Feb 2023 //
MARKETWATCH
F-star gets down to the wire with $161M sale to Chinese buyer
27 Jan 2023 //
ENDPTS
invoX Pharma and F-star Therapeutics issue Joint Statement
26 Jan 2023 //
GLOBENEWSWIRE
US puts hold on F-star`s takeover by China’s Sino Biopharm, security risks
30 Dec 2022 //
ENDPTS
Why The F-Star Therapeutics (FSTX) Stock Plummeted 40.38%
29 Dec 2022 //
PULSE2
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement
20 Dec 2022 //
MARKETSCREENER
In yet another delay for the F-star buyout
20 Dec 2022 //
ENDPTS
F-star Therapeutics Presents Data on FS222, a CD137/PD-L1 at ESMO-IO 2022
06 Dec 2022 //
GLOBENEWSWIRE
F-star Therapeutics Announces Publication of Ph1 Dose-Escalation Trial of FS118
07 Nov 2022 //
GLOBENEWSWIRE
F-star Therapeutics Reports Q2 2022 Rusult and Corporate Highlights
11 Aug 2022 //
GLOBENEWSWIRE
invoX Pharma Extends Tender Offer to Acquire F-star Therapeutics, Inc.
04 Aug 2022 //
BUSINESSWIRE
Takeda weaves F-star tech into patchwork of cancer capabilities
20 Jul 2022 //
FIERCEBIOTECH
invoX Pharma to Acquire F-star Therapeutics
23 Jun 2022 //
GLOBENEWSWIRE
F-star Therapeutics Reports First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
F-star Therapeutics to Announce First Quarter Results
02 May 2022 //
GLOBENEWSWIRE
F-star Tx Presents Novel LAG-3 Reduction and Shedding Mechanism with FS118
08 Apr 2022 //
GLOBENEWSWIRE
F-star Tx to Present at the 32nd Annual Oppenheimer Healthcare Conference
10 Mar 2022 //
GLOBENEWSWIRE
F-star Tx to Host Q4 and Full-Year 2021 Financial Results on March 14
02 Mar 2022 //
GLOBENEWSWIRE
F-star Bags U.S. Patent Protecting FS118, Targeting PD-L1 and LAG-3
20 Jan 2022 //
GLOBENEWSWIRE
Merck takes 4th option on Big Pharma darling F-star`s bispecific
06 Jan 2022 //
FIERCEBIOTECH
F-star Therapeutics to Host Virtual R&D Day on December 6, 2021
29 Dec 2021 //
GLOBNEWSWIRE
F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO
07 Dec 2021 //
GLOBENEWSWIRE
F-Star`s J&J deal is largest yet with $1.35B in biobucks
21 Oct 2021 //
GLOBENEWSWIRE
F-star Therapeutics Announces License Agreement with Janssen
20 Oct 2021 //
GLOBENEWSWIRE
F-star Therapeutics to Present FS120 Phase 1 Trial Update at ESMO 2021
16 Sep 2021 //
GLOBENEWSWIRE
F-star Therapeutics to Announce Second Quarter Results
02 Aug 2021 //
GLOBENEWSWIRE
F-star Therapeutics to Present at Upcoming Investor Conferences
09 Jul 2021 //
GLOBENEWSWIRE
AstraZeneca takes a chance on the STING pathway with F-star
09 Jul 2021 //
ENDPTS
F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca
08 Jul 2021 //
GLOBENEWSWIRE
F-star Granted Composition of Matter Patent for FS118, a Bispecific Antibody
20 Jan 2021 //
GLOBENEWSWIRE
F-star Announces First Patient Dosed in FS222 Ph 1 Clinical Trial
04 Jan 2021 //
GLOBENEWSWIRE
F-star Therapeutics Announces First Patient Dosed in First-in-Class FS120
04 Dec 2020 //
PRNEWSWIRE
F-star Announces First Patient Dosed in First-in-Class FS120 Ph 1 Trial
03 Dec 2020 //
PRNEWSWIRE
F-star Therapeutics Announces Clearance of Clinical Trial Application for FS222
24 Nov 2020 //
PRNEWSWIRE
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals
20 Nov 2020 //
BIOSPACE
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals
20 Nov 2020 //
PRNNEWSWIRE
F-star Therapeutics to Present at SITC 2020 Virtual Annual Meeting
22 Oct 2020 //
PRNEWSWIRE
F-star`s Eliot Forster maps a shortcut to Wall Street, bagging more cash
30 Jul 2020 //
ENDPTS
F-star : Merck KGaA Takes an Early Option in Immuno-Oncology Collaboration
16 Jul 2020 //
BUSINESSWIRE
F-star Announces Positive Preclinical Antitumor Activity and Safety of FS222
28 Apr 2020 //
BUSINESSWIRE
F-star Therapeutics Announces Data on Potent Anti-Tumor Activity of FS120
09 Apr 2020 //
BUSIBNESSWIRE
